339 related articles for article (PubMed ID: 27561138)
1. A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications.
Wilkinson ST; Radhakrishnan R; D'Souza DC
J Clin Psychiatry; 2016 Aug; 77(8):1050-64. PubMed ID: 27561138
[TBL] [Abstract][Full Text] [Related]
2. Medical Cannabinoids in Children and Adolescents: A Systematic Review.
Wong SS; Wilens TE
Pediatrics; 2017 Nov; 140(5):. PubMed ID: 29061872
[TBL] [Abstract][Full Text] [Related]
3. Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review.
Steenkamp MM; Blessing EM; Galatzer-Levy IR; Hollahan LC; Anderson WT
Depress Anxiety; 2017 Mar; 34(3):207-216. PubMed ID: 28245077
[TBL] [Abstract][Full Text] [Related]
4. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.
Hill KP
JAMA; 2015 Jun 23-30; 313(24):2474-83. PubMed ID: 26103031
[TBL] [Abstract][Full Text] [Related]
5. Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite.
Spanagel R; Bilbao A
Neuropharmacology; 2021 Sep; 196():108680. PubMed ID: 34181977
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Whiting PF; Wolff RF; Deshpande S; Di Nisio M; Duffy S; Hernandez AV; Keurentjes JC; Lang S; Misso K; Ryder S; Schmidlkofer S; Westwood M; Kleijnen J
JAMA; 2015 Jun 23-30; 313(24):2456-73. PubMed ID: 26103030
[TBL] [Abstract][Full Text] [Related]
7. The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review.
Hindocha C; Cousijn J; Rall M; Bloomfield MAP
J Dual Diagn; 2020; 16(1):120-139. PubMed ID: 31479625
[No Abstract] [Full Text] [Related]
8. How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review.
Hoch E; Niemann D; von Keller R; Schneider M; Friemel CM; Preuss UW; Hasan A; Pogarell O
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):87-105. PubMed ID: 30706168
[TBL] [Abstract][Full Text] [Related]
9. Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Cannabinoids for Chronic Pain: Protocol for a Systematic Review.
Mohiuddin MM; Mizubuti G; Haroutounian S; Smith S; Campbell F; Park R; Gilron I
JMIR Res Protoc; 2019 Jan; 8(1):e11637. PubMed ID: 30688655
[TBL] [Abstract][Full Text] [Related]
10. Risks and Benefits of Cannabis and Cannabinoids in Psychiatry.
Hill KP; Gold MS; Nemeroff CB; McDonald W; Grzenda A; Widge AS; Rodriguez C; Kraguljac NV; Krystal JH; Carpenter LL
Am J Psychiatry; 2022 Feb; 179(2):98-109. PubMed ID: 34875873
[TBL] [Abstract][Full Text] [Related]
11. Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review.
Orsolini L; Chiappini S; Volpe U; Berardis D; Latini R; Papanti GD; Corkery AJM
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31450833
[TBL] [Abstract][Full Text] [Related]
12. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids: for better and for worse
.
Thibaut F; Hoehe MR
Dialogues Clin Neurosci; 2020 Sep; 22(3):201-204. PubMed ID: 33162763
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of medical cannabinoids in older subjects: a systematic review.
van den Elsen GA; Ahmed AI; Lammers M; Kramers C; Verkes RJ; van der Marck MA; Rikkert MG
Ageing Res Rev; 2014 Mar; 14():56-64. PubMed ID: 24509411
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids: Medical implications.
Schrot RJ; Hubbard JR
Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385
[TBL] [Abstract][Full Text] [Related]
16. [Cannabinoids for neuropathic pain management].
Andersen LØ; Enggaard TP; Højsted J
Ugeskr Laeger; 2018 Feb; 180(9):. PubMed ID: 29506645
[TBL] [Abstract][Full Text] [Related]
17. Peripherally Restricted Cannabinoids for the Treatment of Pain.
Romero-Sandoval EA; Asbill S; Paige CA; Byrd-Glover K
Pharmacotherapy; 2015 Oct; 35(10):917-25. PubMed ID: 26497478
[TBL] [Abstract][Full Text] [Related]
18. [Cannabinoids in palliative care: Systematic review and meta-analysis of efficacy, tolerability and safety].
Mücke M; Carter C; Cuhls H; Prüß M; Radbruch L; Häuser W
Schmerz; 2016 Feb; 30(1):25-36. PubMed ID: 26809975
[TBL] [Abstract][Full Text] [Related]
19. Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.
Belendiuk KA; Baldini LL; Bonn-Miller MO
Addict Sci Clin Pract; 2015 Apr; 10():10. PubMed ID: 25896576
[TBL] [Abstract][Full Text] [Related]
20. The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis.
Goldenberg M; Reid MW; IsHak WW; Danovitch I
Drug Alcohol Depend; 2017 May; 174():80-90. PubMed ID: 28319753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
